Other Species / Isoforms
  SOX9 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T11-p
LDPFMKMtDEQEKGL
0 1
SOX9 (human) LDPFMKMtDEQEKGL T11-p
SOX9 (mouse) LDPFMKMTDEQEKGL T11
SOX9 (chicken) LDPFMKMTEEQDKCI T11
S30-p
SPTMSEDsAGSPCPS
0 1
SOX9 (human) SPTMSEDsAGSPCPS S30-p
SOX9 (mouse) SPTMSEDSAGSPCPS S30
SOX9 (chicken) SPTMSDDSAGSPCPS S30
T43-p
PSGSGSDtENtRPQE
0 1
SOX9 (human) PSGSGSDtENtRPQE T43-p
SOX9 (mouse) PSGSGSDTENTRPQE T43
SOX9 (chicken) PSGSGSDTENTRPQE T43
T46-p
SGSDtENtRPQENTF
0 1
SOX9 (human) SGSDtENtRPQENTF T46-p
SOX9 (mouse) SGSDTENTRPQENTF T46
SOX9 (chicken) SGSDTENTRPQENTF T46
K61-ac
PKGEPDLkKEsEEDk
Upstream
1 0
Treatment
  • siRNA
SOX9 (human) PKGEPDLkKEsEEDk K61-ac
SOX9 (mouse) PKGEPDLKKEsEEDK K61
SOX9 (chicken) PKGDPDLKKEsDEDK K61
K61
PKGEPDLKKEsEEDk
1 0
SOX9 (human) PKGEPDLKKEsEEDk K61
SOX9 (mouse) PKGEPDLKKEsEEDK K61
SOX9 (chicken) PKGDPDLkKEsDEDK K61-sm
S64-p
EPDLkKEsEEDkFPV
Upstream
Downstream
6 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • PKACA (human)
Putative in vivo kinases:
  • PKACA (human)
Treatment
  • BW245C
  • cAMP_analog
  • H-89
  • PGD2
SOX9 (human) EPDLkKEsEEDkFPV S64-p
SOX9 (mouse) EPDLKKEsEEDKFPV S64-p
SOX9 (chicken) DPDLkKEsDEDKFPV S64-p
K68-ub
kKEsEEDkFPVCIRE
0 1
SOX9 (human) kKEsEEDkFPVCIRE K68-ub
SOX9 (mouse) KKEsEEDKFPVCIrE K68
SOX9 (chicken) kKEsDEDKFPVCIRE K68
R74
DkFPVCIREAVsQVL
1 0
SOX9 (human) DkFPVCIREAVsQVL R74
SOX9 (mouse) DKFPVCIrEAVSQVL R74-me
SOX9 (chicken) DKFPVCIREAVSQVL R74
S78-p
VCIREAVsQVLkGYD
0 1
SOX9 (human) VCIREAVsQVLkGYD S78-p
SOX9 (mouse) VCIrEAVSQVLKGYD S78
SOX9 (chicken) VCIREAVSQVLKGYD S78
K82-ub
EAVsQVLkGYDWTLV
0 2
SOX9 (human) EAVsQVLkGYDWTLV K82-ub
SOX9 (mouse) EAVSQVLKGYDWTLV K82
SOX9 (chicken) EAVSQVLKGYDWTLV K82
K141-ac
ELSKTLGkLWRLLNE
0 2
SOX9 (human) ELSKTLGkLWRLLNE K141-ac
SOX9 (mouse) ELSKTLGKLWRLLNE K141
SOX9 (chicken) ELSKTLGKLWRLLNE K141
R152
LLNESEKRPFVEEAE
1 0
SOX9 (human) LLNESEKRPFVEEAE R152
SOX9 (mouse) LLNESEKrPFVEEAE R152-me
SOX9 (chicken) LLNESEKRPFVEEAE R152
R177
PDYKYQPRRRKsVKN
1 0
SOX9 (human) PDYKYQPRRRKsVKN R177
SOX9 (mouse) PDYKYQPrrrKsVKN R177-me
SOX9 (chicken) PDYKYQPRRRKsVKN R177
R178
DYKYQPRRRKsVKNG
1 0
SOX9 (human) DYKYQPRRRKsVKNG R178
SOX9 (mouse) DYKYQPrrrKsVKNG R178-me
SOX9 (chicken) DYKYQPRRRKsVKNG R178
R179
YKYQPRRRKsVKNGQ
1 0
SOX9 (human) YKYQPRRRKsVKNGQ R179
SOX9 (mouse) YKYQPrrrKsVKNGQ R179-me
SOX9 (chicken) YKYQPRRRKsVKNGQ R179
S181-p
YQPRRRKsVKNGQAE
Upstream
Downstream
11 2
Effects on Modified Protein
  • activity, induced
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell differentiation, induced
  • cell motility, induced
  • cytoskeletal reorganization
  • signaling pathway regulation
  • transcription, induced
Kinase, in vitro:
  • PKACA (human)
  • ROCK1 (human)
Putative in vivo kinases:
  • ADCK5 (human)
  • PKACA (human)
  • ROCK1 (human)
Regulatory protein:
  • PTHR (human)
  • RHOA (human)
Treatment
  • BW245C
  • cAMP_analog
  • FGF2
  • H-89
  • hydroxyfasudil
  • okadaic_acid
  • PGD2
  • PTHrP
  • siRNA
  • tamoxifen
  • TGF-beta
SOX9 (human) YQPRRRKsVKNGQAE S181-p
SOX9 (mouse) YQPrrrKsVKNGQAE S181-p
SOX9 (chicken) YQPRRRKsVKNGQSE S181-p
T196-p
AEEATEQtHIsPNAI
0 1
SOX9 (human) AEEATEQtHIsPNAI T196-p
SOX9 (mouse) AEEATEQTHIsPNAI T196
SOX9 (chicken) QEEGSEQTHISPNAI T196
S199-p
ATEQtHIsPNAIFKA
0 6
SOX9 (human) ATEQtHIsPNAIFKA S199-p
SOX9 (mouse) ATEQTHIsPNAIFKA S199-p
SOX9 (chicken) GSEQTHISPNAIFKA S199
S211-p
FKALQADsPHsSSGM
Upstream
Downstream
2 1
Effects on Modified Protein
  • protein stabilization
Effects on Biological Processes:
  • transcription, induced
Putative in vivo kinases:
  • P38A (human)
Regulatory protein:
  • SMAD2 (human)
  • SMAD3 (human)
Treatment
  • SB202190
  • SB203580
  • TGF-beta
SOX9 (human) FKALQADsPHsSSGM S211-p
SOX9 (mouse) FKALQADsPHSSSGM S211-p
SOX9 (chicken) FKALQADSPQSSSSI S211
S214-p
LQADsPHsSSGMSEV
0 1
SOX9 (human) LQADsPHsSSGMSEV S214-p
SOX9 (mouse) LQADsPHSSSGMSEV S214
SOX9 (chicken) LQADSPQSSSSISEV S214
S223-p
SGMSEVHsPGEHSGQ
0 1
SOX9 (human) SGMSEVHsPGEHSGQ S223-p
SOX9 (mouse) SGMSEVHSPGEHSGQ S223
SOX9 (chicken) SSISEVHSPGEHSGQ S223
T236-p
GQSQGPPtPPtTPKT
Upstream
Downstream
2 3
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • apoptosis, induced
  • transcription, altered
Kinase, in vitro:
  • GSK3B (human)
SOX9 (human) GQSQGPPtPPtTPKT T236-p
SOX9 (mouse) GQSQGPPTPPTTPKT T236
SOX9 (chicken) GQSQGPPTPPTTPKT T236
T239-p
QGPPtPPtTPKTDVQ
0 1
SOX9 (human) QGPPtPPtTPKTDVQ T239-p
SOX9 (mouse) QGPPTPPTTPKTDVQ T239
SOX9 (chicken) QGPPTPPTTPKTDAQ T239
K249-ub
KTDVQPGkADLkREG
0 1
SOX9 (human) KTDVQPGkADLkREG K249-ub
SOX9 (mouse) KTDVQAGKVDLKREG K249
SOX9 (chicken) TDAQQPGKQDLkREG K250
K253-ac
QPGkADLkREGRPLP
Upstream
1 0
Treatment
  • siRNA
SOX9 (human) QPGkADLkREGRPLP K253-ac
SOX9 (mouse) QAGKVDLKREGRPLA K253
SOX9 (chicken) QPGKQDLKREGRPLA K254
K253
QPGkADLKREGRPLP
1 0
SOX9 (human) QPGkADLKREGRPLP K253
SOX9 (mouse) QAGKVDLKREGRPLA K253
SOX9 (chicken) QPGKQDLkREGRPLA K254-sm
K398-ac
QSQRTHIkTEQLSPS
Upstream
1 0
Treatment
  • siRNA
SOX9 (human) QSQRTHIkTEQLSPS K398-ac
SOX9 (mouse) QSQRTHIKTEQLSPS K396
SOX9 (chicken) AQQRPHIKTEQLSPS K376
K398
QSQRTHIKTEQLSPS
1 0
SOX9 (human) QSQRTHIKTEQLSPS K398
SOX9 (mouse) QSQRTHIKTEQLSPS K396
SOX9 (chicken) AQQRPHIkTEQLSPS K376-sm
S414-p
YSEQQQHsPQQIAYS
0 1
SOX9 (human) YSEQQQHsPQQIAYS S414-p
SOX9 (mouse) YSEQQQHSPQQISYS S412
SOX9 (chicken) YSEQQQHSPQQQQQQ S392
Y442-p
ITRSQYDyTDHQNSS
0 1
SOX9 (human) ITRSQYDyTDHQNSS Y442-p
SOX9 (mouse) ITRSQYDYADHQNSG Y440
SOX9 (chicken) ITRSQYDYTEHQNSG Y427